Status:
NOT_YET_RECRUITING
Role of ICCO Score in Predicting Outcome in ICU Patients
Lead Sponsor:
Assiut University
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
This study aims at calculating a specific score to cirrhotic patients admitted at ICU (ICCO score) and use this score to predict mortality and outcome for admitted patients.
Detailed Description
Liver cirrhosis is the final stage of chronic liver disease. It is characterized by an irreversible replacement of liver parenchyma with fibrotic tissue and regenerative nodules. The major causes of c...
Eligibility Criteria
Inclusion
- Adult patients (age ≥18 years) with cirrhosis admitted to the ICU.
- Confirmed diagnosis of cirrhosis based on clinical, radiological, and/or histological criteria.
- Need for intensive care management due to acute illness or complications related to cirrhosis.
Exclusion
- Patients without a confirmed diagnosis of cirrhosis.
- Patients with acute liver failure not meeting criteria for cirrhosis.
- Patients with incomplete data for calculating ICCO.
- Patients transferred from another ICU.
- Patients who refuse participation in the study.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT06561477
Start Date
March 1 2025
End Date
May 1 2026
Last Update
January 29 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.